Ayyar VS[au] - Search Results

Year	Number of Results
2011	1
2012	2
2015	1
2017	2
2018	2
2019	5
2020	3
2021	5
2022	2
2023	2
2024	2

1

Pharmacokinetic and Pharmacodynamic Modeling of siRNA Therapeutics - a Minireview.

Jeon JY, Ayyar VS, Mitra A. Jeon JY, et al. Among authors: ayyar vs. Pharm Res. 2022 Aug;39(8):1749-1759. doi: 10.1007/s11095-022-03333-8. Epub 2022 Jul 12. Pharm Res. 2022. PMID: 35819583 Review.

2

Minimal Physiologically Based Pharmacokinetic-Pharmacodynamic (mPBPK-PD) Model of N-Acetylgalactosamine-Conjugated Small Interfering RNA Disposition and Gene Silencing in Preclinical Species and Humans.

Ayyar VS, Song D, Zheng S, Carpenter T, Heald DL. Ayyar VS, et al. J Pharmacol Exp Ther. 2021 Nov;379(2):134-146. doi: 10.1124/jpet.121.000805. Epub 2021 Aug 19. J Pharmacol Exp Ther. 2021. PMID: 34413198

3

CPT: Pharmacometrics & Systems Pharmacology - Inception, Maturation, and Future Vision.

Rowland Yeo K, Hennig S, Krishnaswami S, Strydom N, Ayyar VS, French J, Sinha V, Sobie E, Zhao P, Friberg LE, Mentré F. Rowland Yeo K, et al. Among authors: ayyar vs. CPT Pharmacometrics Syst Pharmacol. 2021 Jul;10(7):649-657. doi: 10.1002/psp4.12680. CPT Pharmacometrics Syst Pharmacol. 2021. PMID: 34298582 Free PMC article. No abstract available.

4

Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.

Ayyar VS, Jusko WJ. Ayyar VS, et al. Pharmacol Rev. 2020 Apr;72(2):414-438. doi: 10.1124/pr.119.018101. Pharmacol Rev. 2020. PMID: 32123034 Free PMC article. Review.

5

Circadian rhythms: influence on physiology, pharmacology, and therapeutic interventions.

Ayyar VS, Sukumaran S. Ayyar VS, et al. J Pharmacokinet Pharmacodyn. 2021 Jun;48(3):321-338. doi: 10.1007/s10928-021-09751-2. Epub 2021 Apr 1. J Pharmacokinet Pharmacodyn. 2021. PMID: 33797011 Free PMC article. Review.

6

Mechanistic Pharmacokinetics and Pharmacodynamics of GalNAc-siRNA: Translational Model Involving Competitive Receptor-Mediated Disposition and RISC-Dependent Gene Silencing Applied to Givosiran.

Ayyar VS, Song D. Ayyar VS, et al. J Pharm Sci. 2024 Jan;113(1):176-190. doi: 10.1016/j.xphs.2023.10.026. Epub 2023 Oct 21. J Pharm Sci. 2024. PMID: 37871778

7

Indirect pharmacodynamic models for responses with circadian removal.

Ayyar VS, Krzyzanski W, Jusko WJ. Ayyar VS, et al. J Pharmacokinet Pharmacodyn. 2019 Feb;46(1):89-101. doi: 10.1007/s10928-019-09620-z. Epub 2019 Jan 29. J Pharmacokinet Pharmacodyn. 2019. PMID: 30694437 Free PMC article.

8

History of growth hormone therapy.

Ayyar VS. Ayyar VS. Indian J Endocrinol Metab. 2011 Sep;15 Suppl 3(Suppl3):S162-5. doi: 10.4103/2230-8210.84852. Indian J Endocrinol Metab. 2011. PMID: 22029019 Free PMC article.

9

Model-Based Cellular Kinetic Analysis of Chimeric Antigen Receptor-T Cells in Humans.

Liu C, Ayyar VS, Zheng X, Chen W, Zheng S, Mody H, Wang W, Heald D, Singh AP, Cao Y. Liu C, et al. Among authors: ayyar vs. Clin Pharmacol Ther. 2021 Mar;109(3):716-727. doi: 10.1002/cpt.2040. Epub 2020 Oct 13. Clin Pharmacol Ther. 2021. PMID: 33002189 Free PMC article.

10

Modeling Corticosteroid Pharmacogenomics and Proteomics in Rat Liver.

Ayyar VS, Sukumaran S, DuBois DC, Almon RR, Jusko WJ. Ayyar VS, et al. J Pharmacol Exp Ther. 2018 Oct;367(1):168-183. doi: 10.1124/jpet.118.251959. Epub 2018 Aug 7. J Pharmacol Exp Ther. 2018. PMID: 30087156 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

24 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year